Study Details | NCT02527564 | Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder (opens in new tab)

The purpose of this study is to evaluate the efficacy of suvorexant, added to existing medications, for treatment-resistant insomnia in individuals with bipolar disorder. The investigators hypothesize that participants receiving suvorexant for one week will experience significantly greater improvement in sleep duration compared to participants receiving placebo.